Candidates must reside in the same country where the role is located

Overview

The Asset Commercialization Partner - Emerging Biopharma (EBP) is a trusted advisor to IQVIA’s EBP clients, incorporating deep expertise in commercialization and launch to support the development, enablement and execution of their commercialization strategies.

The Asset Commercialization Partner will utilize the full spectrum of IQVIA’s resources to develop complex integrated solutions that enable successful commercialization strategies and first-in-class delivery for EBP clients across therapeutic areas in the United States.

The Asset Commercialization Partner will: